People · Operator

Jeffrey T. Zywicki

Named in public records as an officer, director or promoter · active 2018–2023 · Other

1
Companies
10
Filings
$50.0M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
CyMedica Orthopedics, Inc.OtherSeries B$50.0M$108.9M2018
Operator network

Jeffrey T. Zywicki at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Alexander B. Suh · 3 companies · 1 sharedAlexander B. SuhEdwin F. Scheetz · 3 companies · 1 sharedEdwin F. ScheetzChristopher B. Martin · 2 companies · 1 sharedChristopher B. Ma…D. Ronald Yagoda · 2 companies · 1 sharedD. Ronald YagodaRobert Morocco · 2 companies · 1 sharedRobert MoroccoChristopher H. Martin · 1 companies · 1 sharedChristopher H. Ma…Edwin F. Sheetz · 1 companies · 1 sharedEdwin F. SheetzJeff F. Zywicki · 1 companies · 1 sharedJeff F. ZywickiKelley T. Lipman · 1 companies · 1 sharedKelley T. LipmanRhonda F. Anderson · 1 companies · 1 sharedRhonda F. AndersonRhonda T. Anderson · 1 companies · 1 sharedRhonda T. AndersonStruan H. Coleman · 1 companies · 1 sharedStruan H. ColemanWilliam H. Hanna · 1 companies · 1 sharedWilliam H. HannaCyMedica Orthopedics, Inc. · $50.0M raisedCyMedica Orthopedics,…Jeffrey T. ZywickiJZ
Jeffrey T. Zywicki Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Jeffrey T. Zywicki on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Alexander B. Suh13
Edwin F. Scheetz13
Christopher B. Martin12
Robert Morocco12
D. Ronald Yagoda12
Christopher H. Martin11
Rhonda F. Anderson11
Kelley T. Lipman11
Rhonda T. Anderson11
Struan H. Coleman11
Edwin F. Sheetz11
Jeff F. Zywicki11
William H. Hanna11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.